123 related articles for article (PubMed ID: 8993570)
21. Tissue-specific transcriptional modulation of fatty acid-binding protein genes, fabp2, fabp3 and fabp6, by fatty acids and the peroxisome proliferator, clofibrate, in zebrafish (Danio rerio).
Venkatachalam AB; Sawler DL; Wright JM
Gene; 2013 May; 520(1):14-21. PubMed ID: 23466978
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferators: species differences in response of primary hepatocyte cultures.
Elcombe CR; Bell DR; Elias E; Hasmall SC; Plant NJ
Ann N Y Acad Sci; 1996 Dec; 804():628-35. PubMed ID: 8993577
[No Abstract] [Full Text] [Related]
23. The peroxisome proliferators are hepatocyte mitogens in chemically-defined media: glucocorticoid-induced PPAR alpha is linked to peroxisome proliferator mitogenesis.
Plant NJ; Horley NJ; Savory RL; Elcombe CR; Gray TJ; Bell DR
Carcinogenesis; 1998 May; 19(5):925-31. PubMed ID: 9635884
[TBL] [Abstract][Full Text] [Related]
24. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver.
Akbiyik F; Cinar K; Demirpence E; Ozsullu T; Tunca R; Haziroglu R; Yurdaydin C; Uzunalimoglu O; Bozkaya H
Eur J Clin Invest; 2004 Jun; 34(6):429-35. PubMed ID: 15200495
[TBL] [Abstract][Full Text] [Related]
25. A knockout for risk assessment.
Bell DR
Hum Exp Toxicol; 1995 Oct; 14(10):850-1. PubMed ID: 8562126
[No Abstract] [Full Text] [Related]
26. Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element.
Gervois P; Chopin-Delannoy S; Fadel A; Dubois G; Kosykh V; Fruchart JC; Najïb J; Laudet V; Staels B
Mol Endocrinol; 1999 Mar; 13(3):400-9. PubMed ID: 10076997
[TBL] [Abstract][Full Text] [Related]
27. PPARalpha-dependent induction of liver microsomal esterification of estradiol and testosterone by a prototypical peroxisome proliferator.
Xu S; Zhu BT; Turan V; Rusyn I; Thurman R; Peters JM; Gonzalez FJ; Conney AH
Endocrinology; 2001 Aug; 142(8):3554-7. PubMed ID: 11459802
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferators and T3 operate by way of distinct receptors.
Castelein H; Declercq PE; Mannaerts GP; Baes MI
FEBS Lett; 1993 Oct; 332(1-2):24-6. PubMed ID: 8405443
[TBL] [Abstract][Full Text] [Related]
29. An epitope-tagging system for studying regulation of the peroxisome proliferator activated receptor alpha (PPAR alpha).
Owens JM; Tugwood JD; Gibson GG
Eur J Drug Metab Pharmacokinet; 1997; 22(4):325-8. PubMed ID: 9512929
[TBL] [Abstract][Full Text] [Related]
30. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
Schoonjans K; Staels B; Auwerx J
Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
[TBL] [Abstract][Full Text] [Related]
31. Delineating peroxisome proliferator action to improve human risk assessment.
Green S; Issemann I; Tugwood JD; Prince RA; Aldridge TC
Prog Clin Biol Res; 1994; 387():311-33. PubMed ID: 7972256
[No Abstract] [Full Text] [Related]
32. Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway.
Louet JF; Chatelain F; Decaux JF; Park EA; Kohl C; Pineau T; Girard J; Pegorier JP
Biochem J; 2001 Feb; 354(Pt 1):189-97. PubMed ID: 11171094
[TBL] [Abstract][Full Text] [Related]
33. Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation.
Kippenberger S; Loitsch SM; Grundmann-Kollmann M; Simon S; Dang TA; Hardt-Weinelt K; Kaufmann R; Bernd A
J Invest Dermatol; 2001 Dec; 117(6):1430-6. PubMed ID: 11886504
[TBL] [Abstract][Full Text] [Related]
34. Fatty acids bind directly to and activate peroxisome proliferator-activated receptors alpha and gamma.
Wolf G
Nutr Rev; 1998 Feb; 56(2 Pt 1):61-3. PubMed ID: 9529901
[TBL] [Abstract][Full Text] [Related]
35. Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways.
Chu R; Madison LD; Lin Y; Kopp P; Rao MS; Jameson JL; Reddy JK
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11593-7. PubMed ID: 8524810
[TBL] [Abstract][Full Text] [Related]
36. Regulation of fatty acid transport protein and mitochondrial and peroxisomal beta-oxidation gene expression by fatty acids in developing rats.
Ouali F; Djouadi F; Merlet-Bénichou C; Riveau B; Bastin J
Pediatr Res; 2000 Nov; 48(5):691-6. PubMed ID: 11044493
[TBL] [Abstract][Full Text] [Related]
37. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.
Sterchele PF; Sun H; Peterson RE; Vanden Heuvel JP
Arch Biochem Biophys; 1996 Feb; 326(2):281-9. PubMed ID: 8611035
[TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.
Kersten S; Seydoux J; Peters JM; Gonzalez FJ; Desvergne B; Wahli W
J Clin Invest; 1999 Jun; 103(11):1489-98. PubMed ID: 10359558
[TBL] [Abstract][Full Text] [Related]
39. Structural requirements of chiral clofibric acid analogs for activation of the rat peroxisome proliferator-activated receptor alpha.
Feller DR; O'Brien M; Rangwala SM; Tortorella V; Loiodice F; Noonan DJ
Ann N Y Acad Sci; 1996 Dec; 804():713-5. PubMed ID: 8993602
[No Abstract] [Full Text] [Related]
40. The functional efficiency of lipogenic and cholesterogenic gene expression in normal mice and in mice lacking the peroxisomal proliferator-activated receptor-alpha (PPAR-alpha).
Gibbons GF; Patel D; Wiggins D; Knight BL
Adv Enzyme Regul; 2002; 42():227-47. PubMed ID: 12123718
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
